Showing 25 of 415 grants in "Health"
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)
Deadline: February 8, 2029
Opportunity Number: RFA-NS-28-010
Agency: National Institutes of Health
Open Date: September 30, 2026
Close Date: February 8, 2029
Status: Posted
CFDA Numbers: 93.242, 93.867, 93.173, 93.286, 93.865, 93.273, 93.279, 93.853, 93.372, 93.213, 93.866
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
Deadline: October 28, 2027
Opportunity Number: RFA-MH-27-125
Agency: National Institutes of Health
Open Date: September 30, 2026
Close Date: October 28, 2027
Status: Posted
CFDA Numbers: 93.853, 93.242, 93.279
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline: October 30, 2026
Opportunity Number: PAR-27-045
Agency: National Institutes of Health
Open Date: September 28, 2026
Close Date: October 30, 2026
Status: Posted
CFDA Numbers: 93.473, 93.273, 93.866, 93.846, 93.853, 93.121, 93.213, 93.286
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
Deadline: November 16, 2029
Opportunity Number: PAR-28-072
Agency: National Institutes of Health
Open Date: September 25, 2026
Close Date: November 16, 2029
Status: Posted
CFDA Numbers: 93.867
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
Deadline: May 25, 2027
Opportunity Number: PAR-28-057
Agency: National Institutes of Health
Open Date: September 25, 2026
Close Date: May 25, 2027
Status: Posted
CFDA Numbers: 93.393
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
Deadline: November 5, 2029
Opportunity Number: PAR-28-056
Agency: National Institutes of Health
Open Date: September 25, 2026
Close Date: November 5, 2029
Status: Posted
CFDA Numbers: 93.393
Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
Deadline: November 10, 2026
Opportunity Number: RFA-OD-27-009
Agency: National Institutes of Health
Open Date: September 24, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.859, 93.310
Advancing Global Health
Deadline: February 14, 2027
Opportunity Number: DFOP0017890
Agency: Bureau of Global Health Security and Diplomacy
Open Date: September 21, 2026
Close Date: February 14, 2027
Status: Posted
CFDA Numbers: 19.029
Fiscal Year (FY) 2027 Service Area Competition (SAC)
Deadline: October 19, 2026
Opportunity Number: HRSA-27-005
Agency: Health Resources and Services Administration
Open Date: September 18, 2026
Close Date: October 19, 2026
Status: Posted
CFDA Numbers: 93.224
National Indian Health Outreach and Education
Deadline: November 2, 2026
Opportunity Number: HHS-2026-IHS-NIHOE-0001
Agency: Indian Health Service
Open Date: September 9, 2026
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.00L
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)
Deadline: April 17, 2029
Opportunity Number: PAR-27-051
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: April 17, 2029
Status: Posted
CFDA Numbers: 93.853, 93.279, 93.121, 93.242, 93.273, 93.399
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
Deadline: July 16, 2028
Opportunity Number: PAR-27-096
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: July 16, 2028
Status: Posted
CFDA Numbers: 93.361, 93.121, 93.307, 93.866
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)
Deadline: June 12, 2028
Opportunity Number: PAR-27-112
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: June 12, 2028
Status: Posted
CFDA Numbers: 93.866
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
Deadline: November 10, 2026
Opportunity Number: RFA-AI-27-005
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.855
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
Deadline: November 10, 2026
Opportunity Number: RFA-AI-27-002
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.855
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
Deadline: October 9, 2028
Opportunity Number: RFA-AI-27-014
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: October 9, 2028
Status: Posted
CFDA Numbers: 93.839, 93.837, 93.853, 93.840, 93.846, 93.867, 93.855, 93.233, 93.279, 93.838
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
Deadline: May 25, 2028
Opportunity Number: PAR-27-127
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: May 25, 2028
Status: Posted
CFDA Numbers: 93.242
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
Deadline: November 10, 2026
Opportunity Number: RFA-AG-27-010
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.866
Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
Deadline: November 6, 2026
Opportunity Number: RFA-DK-27-125
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: November 6, 2026
Status: Posted
CFDA Numbers: 93.847
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
Deadline: November 9, 2026
Opportunity Number: RFA-DK-27-112
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: November 9, 2026
Status: Posted
CFDA Numbers: 93.847
NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
Deadline: March 9, 2029
Opportunity Number: PAR-27-065
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: March 9, 2029
Status: Posted
CFDA Numbers: 93.853
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)
Deadline: June 23, 2028
Opportunity Number: RFA-NS-27-002
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: June 23, 2028
Status: Posted
CFDA Numbers: 93.279, 93.242, 93.853, 93.867, 93.286, 93.372, 93.866, 93.865, 93.173, 93.213, 93.273
Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)
Deadline: January 25, 2027
Opportunity Number: PAR-28-062
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: January 25, 2027
Status: Posted
CFDA Numbers: 93.399
Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)
Deadline: October 2, 2028
Opportunity Number: PAR-27-068
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: October 2, 2028
Status: Posted
CFDA Numbers: 93.859
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)
Deadline: July 7, 2028
Opportunity Number: PAR-27-076
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: July 7, 2028
Status: Posted
CFDA Numbers: 93.855, 93.233, 93.838, 93.840, 93.879, 93.307, 93.839, 93.273, 93.372, 93.853, 93.310, 93.113, 93.173, 93.398, 93.847, 93.865, 93.242, 93.866, 93.121, 93.213, 93.837